PACB
Pacific Biosciences of California Inc

14,454
Mkt Cap
$528.65M
Volume
8.35M
52W High
$2.66
52W Low
$0.8511
PE Ratio
-0.81
PACB Fundamentals
Price
$1.76
Prev Close
$1.78
Open
$1.76
50D MA
$1.55
Beta
2.22
Avg. Volume
10M
EPS (Annual)
-$1.59
P/B
8.60
Rev/Employee
$267,850.43
Loading...
Loading...
News
all
press releases
Pacific Biosciences of California Sees Unusually High Options Volume (NASDAQ:PACB)
Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) was the recipient of some unusual options trading on Thursday. Stock investors purchased 3,953 call options on the stock. This...
MarketBeat·20h ago
News Placeholder
More News
News Placeholder
Pacific Biosciences of California (NASDAQ:PACB) Releases Earnings Results
Pacific Biosciences of California (NASDAQ:PACB - Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported ($0.12) EPS for the quarter, beating analysts...
MarketBeat·1d ago
News Placeholder
PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y
PacBio posts a narrower Q3 loss and margin gains, but shares fall as revenues dip amid softer instrument demand.
Zacks·2d ago
News Placeholder
Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics
Although the revenue and EPS for Pacific Biosciences (PACB) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·2d ago
News Placeholder
Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of +25.00% and -3.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Pacific Biosciences (PACB), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Zacks·4d ago
News Placeholder
Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note
Pacific Biosciences of California (PACB) concluded the recent trading session at $1.97, signifying a -5.74% move from its prior day's close.
Zacks·11d ago
News Placeholder
Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know
Pacific Biosciences of California (PACB) reached $1.9 at the closing of the latest trading day, reflecting a -4.04% change compared to its last close.
Zacks·18d ago
News Placeholder
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
PACB unveils new SPRQ-Nx chemistry to cut sequencing costs and boost multiomic features on Revio and Vega.
Zacks·19d ago
News Placeholder
Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.59, marking a -1.85% move from the previous day.
Zacks·25d ago

Latest PACB News

View

Advertisement|Remove ads.

Advertisement|Remove ads.